Tempus (Tem Stock) is a tech company that uses AI and data science to improve precision medicine, especially in cancer treatment. They assist doctors in making tailored treatment choices by looking at clinical, molecular, and genetic information. They work on genomic sequencing, matching clinical trials, and providing decision support. They team up with hospitals and pharmaceutical companies to enhance patient care and speed up research. The predictions for future stock prices rely on several factors, including market conditions, how well a company is doing, and trends in the industry, along with thorough financial analysis.
Analyst projections for Tempus AI’s stock price over the next 12 months are as follows

Metric | Value |
---|---|
Average Target Price | $61.22 |
Low Estimate | $52 |
High Estimate | $74 |
Analyst Consensus | Buy |
TEM Stock Financial forecasts indicate significant growth
Metric | 2025 Forecast | 2026 Forecast | 2027 Forecast |
---|---|---|---|
Revenue | $1.25B | $1.53B | $1.91B |
Revenue Growth | 80.13% | 22.66% | 24.35% |
EPS | -$0.68 | $0.14 | N/A |
Long-term price predictions for Tempus AI’s stock are as follows:
Year | Price Target |
---|---|
2025 | $58 |
2026 | $76 |
2027 | $92 |
2028 | $117 |
2029 | $185 |
2030 | $290 |
Please note that these long-term forecasts are speculative and subject to various factors, including market conditions, company performance, and industry trends. It’s essential to conduct thorough research and consult with a financial advisor before making investment decisions.
For the most current stock price information, refer to the following data:
TEM Company Overview
Company Name | Tempus AI, Inc. |
Founded | 2015 |
Headquarters | Chicago, Illinois, United States |
Industry | Health technology |
CEO | Eric Lefkofsky |
Stock Exchange Listing | Nasdaq: TEM |
Official Website | www.tempus.com |
Tempus AI (TEM) Stock Forecast & Price Prediction 2025-2030 – FAQ
1. What is Tempus AI (TEM) and why is it important?
Tempus AI Inc. (NASDAQ: TEM) is a leading artificial intelligence company focused on revolutionizing healthcare through data-driven insights. Its cutting-edge technology enhances precision medicine, making it a promising company with strong growth potential.
2. What is the current price of TEM stock?
As of March 13, 2025, Tempus AI (TEM) is trading at $43.12 per share. The stock has shown strong market interest and is expected to gain momentum.
3. What is the TEM stock forecast for 2025?
Analysts predict steady growth for Tempus AI in 2025, with a 12-month price target of $61.22, a low estimate of $52, and a high estimate of $74.
4. What are the long-term price predictions for TEM stock (2026-2030)?
According to market forecasts, TEM stock is expected to experience substantial growth over the next few years:
- 2025: $58
- 2026: $76
- 2027: $92
- 2028: $117
- 2029: $185
- 2030: $290
5. What factors are driving the growth of Tempus AI?
- Advancements in AI-powered healthcare solutions
- Rising demand for precision medicine and data analytics
- Strong revenue growth (80.13% forecasted in 2025)
- Potential profitability by 2026
- Expanding partnerships and market presence
6. Is Tempus AI (TEM) a good investment?
With its strong growth outlook, innovative technology, and increasing market demand, Tempus AI presents a promising long-term investment opportunity. However, investors should consider market conditions and conduct thorough research before investing.
7. What risks should investors be aware of?
- Stock market volatility
- Competition in AI and healthcare sectors
- Regulatory changes impacting AI in medicine
8. Where can I track Tempus AI’s stock performance?
You can monitor TEM stock on financial websites like:
- Yahoo Finance
- Nasdaq
- StockAnalysis
9. Should I invest in Tempus AI for the long term?
If you believe in the future of AI in healthcare and are looking for a high-growth opportunity, Tempus AI could be a valuable long-term investment. However, it’s always best to consult a financial advisor before making any investment decisions.
(Disclaimer: Stock investments involve risk. Past performance is not a guarantee of future results.)